SCHEMBL25820797

SCHEMBL25820797

Cc1cc(Nc2ccc3c(c2)C(=O)N(c2cc(Oc4ccccc4)ccn2)C3)ccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 1/20 0.36
CBLB Q13191 2/20 0.35
P2RX3 P56373 5/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
KDR P35968 2/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GRM4 Q14833 1/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24010362 0.93 P2RX3 (0.35) CBLBP2RX3GRM4MAP3K5
SCHEMBL25820805 0.90 SCN9A (0.36) GCKCBLBMAPTALDH1A1GAA
SCHEMBL25820799 0.89 NPC1 (0.38) GCKCBLBGAAKDRLMNA
SCHEMBL25827154 0.86 SCN9A (0.39) CBLBMAPK1GRM4NFKB1NR2C2
SCHEMBL24010356 0.86 MAPK13 (0.38) CBLBP2RX3GAATSHRKDR
SCHEMBL25820876 0.82 NPC1 (0.38) GAAKDRLMNAHTTKDM4E
SCHEMBL25821627 0.79 NPC1 (0.41) CBLBGAAKDRLMNAMAPK1
SCHEMBL24003929 0.78 CYP11B2 (0.39) P2RX3KDRNPC1RAB9AMAP3K5
SCHEMBL23999768 0.77 NPC1 (0.40) P2RX3MAPTKDM4ENPC1TP53
SCHEMBL23999779 0.77 P2RX3 (0.36) P2RX3MAP3K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA GCK 1024/4885CBLB 3851/4885P2RX3 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.